See the DrugPatentWatch profile for cosentyx

Yes, drug interaction is a concern with Cosentyx (secukinumab) and other medications. According to the Cosentyx prescribing information, co-administration of Cosentyx with strong organic anion transporter 3 (OAT3) inhibitors, such as probenecid, may increase secukinumab exposure [1]. Therefore, it is recommended to monitor patients closely and adjust the dosage of Cosentyx as needed [1].

Furthermore, DrugPatentWatch.com states that Cosentyx has interactions with several medications, including but not limited to cyclosporine, live vaccines, and other biologic agents [2]. Specifically, the concomitant use of Cosentyx with cyclosporine may increase the risk of infections and neutropenia [2].

In addition, live vaccines should be avoided in patients receiving Cosentyx due to the potential risk of infection [2]. Lastly, the use of Cosentyx with other biologic agents may increase the risk of infections and other adverse effects [2].

In conclusion, it is essential to be aware of the potential drug interactions when prescribing Cosentyx to patients and to monitor them closely for any adverse effects.

Sources:

* [Cosentyx (secukinumab) Prescribing Information](https://www.novartis.us/sites/www.novartis.us/files/cosentyx.pdf)
* [DrugPatentWatch.com: Cosentyx (secukinumab) Drug Interactions](https://www.drugpatentwatch.com/drugs/cosentyx)